TrialActa orthopaedica2016

No medium-term advantage of electrochemical deposition of hydroxyapatite in cementless femoral stems. 5-year RSA and DXA results from a randomized controlled trial.

Bernhard Flatøy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.